Søgning
Søgning på udtrykket 'covid' giver 53 resultater
Dokumenter [9]
Sider [3]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem.
Ændringer siden version 29:
Indikationer for COVID-19 test er tilføjet.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske
minoriteters sundhed
Invitation til møde den 20. maj 2022
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er).
Dette holdningspapir omhandler baggrunden for anbefalingen.
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
…
Borrelia:
Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson
Borrelia klaringsrapport (2014),
Diagnostik og behandling af Lyme neuroborreliose (2021),
COVID-19:
Behandling af COVID-19:
Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese
COVID-19 retningslinje (2024v28),
Post-COVID-19:
Jacob Bodilsen, Christian Brandt, Stine Jo.
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå.
Vaccinationer:
Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion.
Pneumokokker.
Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne.
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
17.01.2025
by Bethlehem Berhanu Minassie, Wondwossen Amogne Degu, Eyob Kebede Etissa, Natnael Fitsum Asfeha, Salem Taye Alemayehu, Dawit Kebede Huluka . Background It is now recognized that many patients have persistent symptoms after recovery from acute COVID-19 infection, an infection caused by the coronavirus SARS-CoV-2. This constellation of symptoms known as ‘Long COVID’ may manifest with a wide range of physical and cognitive/psychological symptoms.
Infection
17.01.2025
. Abstract. The Post COVID-19 condition (PCC) is a complex disease affecting health and everyday functioning. This is well reflected by a patient’s inability to work (ITW). In this study, we aimed to investigate factors associated with ITW (1) and to design a machine learning-based model for predicting ITW (2) twelve months after baseline. We selected patients from the post COVID care study (PCC-study) with data on their ability to work.
Journal of Medical Virology
17.01.2025
Journal of Medical Virology, Volume 97, Issue 1, January 2025.
BMJ Open
17.01.2025
. Background. COVID-19 disease results in disparate responses between individuals and has led to the emergence of long coronavirus disease (Long-COVID), characterised by persistent and cyclical symptomology. To understand the complexity of Long-COVID, the importance of symptom surveillance and prospective longitudinal studies is evident. . Methods.
BMJ Open
17.01.2025
. Objective. This study aimed to assess the impact of the COVID-19 pandemic on the characteristics and outcomes of patients with burns in a burn centre situated in Northwest China. . Design. A retrospective descriptive study. . Setting. This study was conducted in Tangdu Hospital, a major regional burn centre in Xi'an, Shaanxi Province of China. . Participants.
BMC Infectious Diseases
17.01.2025
. Abstract. . Background. Low blood absolute lymphocyte count (ALC) may predict severe COVID-19 outcomes. Knowledge gaps remain regarding the relationship of ALC trajectory with clinical outcomes and factors associated with lymphopenia. . . . Methods.
BMC Infectious Diseases
17.01.2025
. Abstract. . Background. Cirrhosis has been pointed out as a clinical entity that leads to worse clinical prognosis in COVID-19 patients. However, this concept is controversial in the literature. We aimed to evaluate clinical outcomes by comparing patients with cirrhosis to those without cirrhosis in a Brazilian cohort. . . . Methods.
BMC Infectious Diseases
17.01.2025
. Abstract. . Background. C-reactive protein (CRP) is one of the most commonly monitored inflammatory markers in patients with COVID-19 to gain insight into the inflammation level in the body and to adopt effective disease management and therapeutic strategies.
Science
17.01.2025
Science, Volume 387, Issue 6731, Page 229-229, January 2025.
Lancet
17.01.2025
The UK's COVID-19 Inquiry is undertaking the biggest public engagement exercise in a public inquiry, hearing from more than 53 000 people. Jacqui Thornton reports.
BMC Infectious Diseases
16.01.2025
. Abstract. . Background. Cirrhosis has been pointed out as a clinical entity that leads to worse clinical prognosis in COVID-19 patients. However, this concept is controversial in the literature. We aimed to evaluate clinical outcomes by comparing patients with cirrhosis to those without cirrhosis in a Brazilian cohort. . . . Methods.
BMC Infectious Diseases
15.01.2025
. Abstract. . Background. Low blood absolute lymphocyte count (ALC) may predict severe COVID-19 outcomes. Knowledge gaps remain regarding the relationship of ALC trajectory with clinical outcomes and factors associated with lymphopenia. . . . Methods.
BMC Infectious Diseases
15.01.2025
. Abstract. . Background. C-reactive protein (CRP) is one of the most commonly monitored inflammatory markers in patients with COVID-19 to gain insight into the inflammation level in the body and to adopt effective disease management and therapeutic strategies.
Emerg Microbes Infect
14.01.2025
Volume 14, Issue 1, December 2025 .
PLoS One Infectious Diseases
14.01.2025
…he ability of a system to prepare, manage, and learn from shocks. This study investigates the resilience of the German health system by analysing the system-related factors that supported health care workers, a key building block of the system, during the COVID-19 pandemic. We thematically analysed data from 18 semi-structured interviews with key informants from management, policy and academia, 17 in-depth interviews with health care workers, and 10 focus group discussions with health care workers.
Journal of the American Medical Association
14.01.2025
Receiving COVID-19 and influenza vaccines at the same time should generate a similar reaction as receiving them separately.
Journal of the American Medical Association
14.01.2025
New research suggests SARS-CoV-2 infection may increase the long-term risk of autoimmune or autoinflammatory connective tissue disorders.
Journal of Infectious Diseases
14.01.2025
BMJ Open
12.01.2025
. Objectives. This study aimed to explore the perceptions of donation coordinators in Canada and understand how the COVID-19 pandemic impacted their work activities. . Design. A sequential mixed-method design incorporating a cross-sectional survey investigating demographic data, substance use and abuse and perceived stress related to the pandemic and semistructured qualitative interviews to further investigate those. . Setting. Organ donation organisations across Canada. . Participants.
BMC Infectious Diseases
12.01.2025
. Abstract. . Background. Limited information is available regarding the changes in blood culture utilization following the COVID-19 pandemic. Blood culture utilization rate is a critical indicator of diagnostic efficiency for infectious diseases. This study aims to describe the impact of the COVID-19 pandemic on blood culture utilization rate in Shanghai. . . .
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Eurosurveillance latest updates
17.01.2025
…arainfluenza viruses (HPIV) commonly cause upper respiratory tract infections, with potential for severe lower respiratory complications. Understanding seasonal increases informs strategies to prevent HPIV spreading. . . Aim . We examined the impact of COVID-19 on HPIV epidemiological and clinical patterns in Scotland using non-sentinel and sentinel surveillance data. . . Methods .
Morbidity and Mortality Weekly Report (MMWR)
17.01.2025
This report describes barriers to health care providers seeking mental health care during the COVID-19 pandemic.
Medscape Infectious Diseases
16.01.2025
Most US states are reporting high or very high flu-like activity, while COVID-19 rates remain lower than this time last year. . WebMD Health News
ProMED
13.01.2025
. . . RESPIRATORY INFECTIONS - ALGERIA:
COVID-19 SUBVARIANT, SUSPECTED,. REQUEST FOR INFORMATION. *****************************************************************************************. A ProMED-mail post.
www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases.
www.isid.org . Date: Tue 7 Jan 2025 . Source: El-Khabar [in Arabic, trans. Mod.MM, abridged, edited] .
bit.ly/4jen7E0 . . .
Morbidity and Mortality Weekly Report (MMWR)
12.01.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Morbidity and Mortality Weekly Report (MMWR)
11.01.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Medscape Infectious Diseases
24.12.2024
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from Eli Lilly and. . Reuters Health Information
Medscape Infectious Diseases
24.12.2024
Long COVID appears to be more prevalent in young and middle-aged adults and may not be taken as seriously as in other age groups, resulting in compromised lives. . Medscape Medical News
Medscape Infectious Diseases
24.12.2024
At a recent congress in Berlin, Germany, clinicians were updated as to recent findings on post-COVID syndromes among children and adolescents. . Medscape Medical News
Statens Serum Institut
20.12.2024
Covid-19 er på et væsentligt lavere blus end sidste år. Til gengæld er smitten med influenza og RS-virus stigende, og Mycoplasma er også på spil.
Morbidity and Mortality Weekly Report (MMWR)
20.12.2024
This report describes adults with Long COVID and reported limitations performing daily activities.
Morbidity and Mortality Weekly Report (MMWR)
20.12.2024
This report describes a decrease in reporting of human adenoviruses cases to the National Adenovirus Type Reporting System since the COVID-19 pandemic.
Medscape Infectious Diseases
18.12.2024
New data show significant state and regional variations in long COVID rates, and experts think they know why. . Medscape Medical News
Medscape Infectious Diseases
17.12.2024
Researchers assess what people with long COVID must deal with when trying to return to work, and how physicians can help. . Medscape Infectious Diseases
Medscape Infectious Diseases
14.12.2024
Europe has approved two drugs for preventing COVID-19 infection: a monoclonal antibody and a self-amplifying mRNA vaccine. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
13.12.2024
This report describes CDC's recommendation that all people aged ≥65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.
Eurosurveillance latest updates
13.12.2024
. Background. The COVID-19 pandemic resulted in increased mortality directly and indirectly associated with COVID-19. . . Aim. To assess the impact of the COVID-19 pandemic on all-cause and disease-specific mortality and explore potential health inequalities associated with area-level deprivation in Wales. . . Methods.
Medscape Infectious Diseases
12.12.2024
As of December 2, according to the CDC, just 19.7% of the US adult population and 9.4% of children had gotten the updated vaccine. . WebMD Health News
Medscape Infectious Diseases
5.12.2024
Vocal patient advocates and researchers argue that certain drugs could help long COVID sufferers via off-label use. Some have already seen positive results. . Medscape Medical News
Medscape Infectious Diseases
3.12.2024
A clinical trial with long-term follow-up found that administering BCG vaccine during the active phase of COVID-19 appeared to offer protection against long COVID symptoms. . Medscape Medical News